However, when they used BM cells, a heterogeneous population that includes myeloid progenitors, in a GM-CSF, IL-4, and 20% tumor supernatant culture, those progeny were functionally impaired in their ability to activate T cells. The gene discussed is CSF2; the disease is neoplasm.